omegaven
Showing 1 - 25 of 73
Omegaven in Pediatric Parenteral Nutrition-Associated
Withdrawn
- Parenteral Nutrition Associated Liver Disease
- +4 more
- Omegaven® (fish oil triglycerides) Injectable Emulsion
- (no location specified)
Aug 2, 2022
Parenteral Nutrition Associated Liver Disease Trial (Omegaven)
Approved for marketing
- Parenteral Nutrition Associated Liver Disease
- Omegaven
- (no location specified)
May 7, 2021
Parenteral Nutrition-related Hepatitis Trial in Kansas City (Omegaven)
Completed
- Parenteral Nutrition-related Hepatitis
- Omegaven
-
Kansas City, MissouriChildren's Mercy Hospitals and Clinics
Jun 1, 2021
Hematopoietic Stem Cell Transplantation Trial in Boston (Omegaven, Soybean oil lipid emulsion)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Omegaven
- Soybean oil lipid emulsion
-
Boston, MassachusettsBoston Children's Hospital
Jun 9, 2022
Parenteral Nutrition Associated Liver Disease Trial in Nashville (Omegaven)
Completed
- Parenteral Nutrition Associated Liver Disease
- Omegaven
-
Nashville, TennesseeMonroe Carell Jr Children's Hospital at vanderbilt
Dec 11, 2020
Cholestasis Trial in San Diego (Omegaven)
No longer available
- Cholestasis
- Omegaven
-
San Diego, California
- +1 more
Jan 7, 2021
Cholestasis, Cholestasis of Parenteral Nutrition Trial in Tampa (Omegaven)
Completed
- Cholestasis
- Cholestasis of Parenteral Nutrition
- Omegaven
-
Tampa, FloridaUSF Health
Jul 7, 2020
Parenteral Nutrition Associated Cholestasis Trial in Sacramento (Omegaven)
Completed
- Parenteral Nutrition Associated Cholestasis
- Omegaven
-
Sacramento, CaliforniaUniversity of California Davis Medical Center
Jan 25, 2021
Cholestasis, Cholestasis of Parenteral Nutrition Trial in Houston (Omegaven)
Completed
- Cholestasis
- Cholestasis of Parenteral Nutrition
- Omegaven
-
Houston, Texas
- +1 more
May 26, 2021
Retinopathy of Prematurity Trial in La Jolla (Omegaven, Standard lipids (primarily omega-6 fatty acids))
Completed
- Retinopathy of Prematurity
- Omegaven
- Standard lipids (primarily omega-6 fatty acids)
-
La Jolla, CaliforniaUniversity of California, San Diego Jacobs Medical Center
Dec 13, 2021
Cholestasis, Parenteral Nutrition Trial in Boston (Omegaven, Intralipid)
Completed
- Cholestasis
- Parenteral Nutrition
- Omegaven
- Intralipid
-
Boston, MassachusettsChildrens's Hospital Boston
Dec 1, 2020
Cholestasis Trial in Cincinnati (Omegaven)
Completed
- Cholestasis
- Omegaven
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jun 8, 2020
Cholestasis Trial in Los Angeles (Omegaven)
Terminated
- Cholestasis
- Omegaven
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Feb 11, 2020
Total Parenteral Nutrition-induced Cholestasis Trial in New York (Omegaven IV lipid emulsion)
Withdrawn
- Total Parenteral Nutrition-induced Cholestasis
- Omegaven IV lipid emulsion
-
New York, New YorkColumbia Presbyterian Medical Center-Children's Hospital of NY
Feb 4, 2020
High Dose Intravenous Fish Oil Reduces Inflammation
Completed
- Lipid Metabolism Disorders
- Omegaven
-
Skawina, PolandStanley Dudrick's Memorial Hospital
Jul 19, 2020
Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis Trial in Omaha (Omegaven™)
Completed
- Parenteral Nutrition Associated Liver Disease PNALD
- Cholestasis
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 4, 2019
Total Parenteral Nutrition-induced Cholestasis, Cholestasis, Short Bowel Syndrome Trial in Oklahoma City (Omegaven)
Completed
- Total Parenteral Nutrition-induced Cholestasis
- +6 more
- Omegaven
-
Oklahoma City, OklahomaOU Children's Hospital
Nov 19, 2019
Gastric Cancer Trial in Bialystok (Early postoperative enteral nutrition, based on standard elementary diet (Peptisorb),
Unknown status
- Gastric Cancer
- Early postoperative enteral nutrition, based on standard elementary diet (Peptisorb)
- +3 more
-
Bialystok, Podlaskie, PolandMedical University of Bialystok
Mar 16, 2020
Parenteral Nutrition Associated Liver Disease Trial in Boise (Omegaven)
No longer available
- Parenteral Nutrition Associated Liver Disease
- Omegaven
-
Boise, IdahoSt. Luke's Pediatric Gastroenterology
Apr 8, 2019
Liver Injury Trial in Los Angeles (Omegaven™, Historical Controls)
Completed
- Liver Injury
- Omegaven™
- Historical Controls
-
Los Angeles, CaliforniaChildrens Hospital Los Angeles
May 2, 2019
Total Parenteral Nutrition-induced Cholestasis Trial in Pittsburgh (Omegaven®)
Approved for marketing
- Total Parenteral Nutrition-induced Cholestasis
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Apr 19, 2019
Cholestasis, Short Bowel Syndrome Trial in Philadelphia (Omegaven)
Approved for marketing
- Cholestasis
- Short Bowel Syndrome
- Omegaven
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Apr 10, 2019
Total Parenteral Nutrition-induced Cholestasis Trial in San Antonio (Omegaven)
Completed
- Total Parenteral Nutrition-induced Cholestasis
- Omegaven
-
San Antonio, TexasChildren's Hospital of San Antonio
Apr 18, 2019